Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 26 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the effects of acute insulin-induced hypoglycemia on inflammation, endothelial dysfunction, and platelet activation in adults with and without type 1 diabetes. RESEARCH DESIGN AND METHODS: We studied 16 nondiabetic adults and 16 subjects with type 1 diabetes during euglycemia (blood glucose 4.5 mmol/l) and hypoglycemia (blood glucose 2.5 mmol/l). Markers of inflammation, thrombosis, and endothelial dysfunction (soluble P-selectin, interleukin-6, von Willebrand factor [vWF], tissue plasminogen activator [tPA], high-sensitivity C-reactive protein [hsCRP], and soluble CD40 ligand [sCD40L]) were measured; platelet-monocyte aggregation and CD40 expression on monocytes were determined using flow cytometry. RESULTS: In nondiabetic participants, platelet activation occurred after hypoglycemia, with increments in platelet-monocyte aggregation and P-selectin (P ≤ 0.02). Inflammation was triggered with CD40 expression increasing maximally at 24 h (3.13 ± 2.3% vs. 2.06 ± 1.0%) after hypoglycemia (P = 0.009). Both sCD40L and hsCRP (P = 0.02) increased with a nonsignificant rise in vWF and tPA, indicating a possible endothelial effect. A reduction in sCD40L, tPA, and P-selectin occurred during euglycemia (P = 0.03, P ≤ 0.006, and P = 0.006, respectively). In type 1 diabetes, both CD40 expression (5.54 ± 4.4% vs. 3.65 ± 1.8%; P = 0.006) and plasma sCD40L concentrations increased during hypoglycemia (peak 3.41 ± 3.2 vs. 2.85 ± 2.8 ng/ml; P = 0.03). Platelet-monocyte aggregation also increased significantly at 24 h after hypoglycemia (P = 0.03). A decline in vWF and P-selectin occurred during euglycemia (P ≤ 0.04). CONCLUSIONS: Acute hypoglycemia may provoke upregulation and release of vasoactive substances in adults with and without type 1 diabetes. This may be a putative mechanism for hypoglycemia-induced vascular injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Acute hypoglycemia is proinflammatory, increases platelet activation and decreases fibrinolysis, leading to a prothrombotic state (65,66).”
From Hypoglycemia (2018) · cites this paper as [65]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“While supported by anecdotal reports (3), the increase in cardiovascular mortality in people with type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial (4) (and possibly in the Veterans Affairs Diabetes Trial [5]), in which intensive treatment had tripled the frequency of severe hypog…”
ResultWinearls, C., Pippard, M., Downing, M., Oliver, D., Reid, C., & Mary Cotes, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92192-6 · Cited by 1,401
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Self-citationAbumrad, N. N., Rabin, D., Diamond, M. P., & Lacy, W. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90074-3 · Cited by 567
CD40 Signaling and Plaque Instability
Schönbeck, U., & Libby, P. (2001) · Circulation Research · doi:10.1161/hh2401.101272 · Cited by 566 · cited 1×
“Monocyte CD40 expression also increased, suggesting promotion of the interaction of the CD40-CD40 ligand dyad (from the tumor necrosis factor receptor family), thus affecting another process in the pathway leading to atherosclerotic plaque rupture (19,20).”
BackgroundVascular disease and diabetes: Is hypoglycaemia an aggravating factor?
Wright, R. J., & Frier, B. M. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.865 · Cited by 336 · cited 1×
“While supported by anecdotal reports (3), the increase in cardiovascular mortality in people with type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial (4) (and possibly in the Veterans Affairs Diabetes Trial [5]), in which intensive treatment had tripled the frequency of severe hypog…”
ResultSelf-citationProinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects
Razavi Nematollahi, L., Kitabchi, A. E., Stentz, F. B., Wan, J. Y., Larijani, B. A., Tehrani, M. M., Gozashti, M. H., Omidfar, K., & Taheri, E. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.018 · Cited by 210
Research works printed but not linked: 1
- Thompson, 1993, Endocrine changes during insulin-induced hypoglycaemia, 116
Cited by
Items 101–200 of 208
Lo, S., Yang, Y., Kornelius, E., Huang, J., Lai, Y., Huang, C., & Chiou, J. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13746 · Cited by 14
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE
Heller, S. R., Lingvay, I., Marso, S. P., Philis‐Tsimikas, A., Pieber, T. R., Poulter, N. R., Pratley, R. E., HACHMANN-NIELSEN, E., Kvist, K., Lange, M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14049 · Cited by 15
The Role of Platelets in Hypoglycemia-Induced Cardiovascular Disease: A Review of the Literature
Ali, A. A. G., Niinuma, S. A., Moin, A. S. M., Atkin, S. L., & Butler, A. E. (2023) · Biomolecules · doi:10.3390/biom13020241 · Cited by 14
“More recently, a randomized controlled trial found that hypoglycemia induces platelet activation and increases platelet-monocyte aggregation and P-selectin (a marker for platelet activation) [40].”
BackgroundVerhulst, C. E. M., van Heck, J. I. P., Fabricius, T. W., Stienstra, R., Teerenstra, S., McCrimmon, R. J., Tack, C. J., Pedersen‐Bjergaard, U., & de Galan, B. E. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15205 · Cited by 14
Xu, C., Li, H., Xu, Q., Zhao, K., Hao, M., Lin, W., Ma, X., Gao, X., & Kuang, H. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108631 · Cited by 15
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Kuribayashi, N., Osonoi, T., Kaneto, H., Kosugi, K., Umayahara, Y., Gosho, M., et al. (2017) · Scientific Reports · doi:10.1038/srep39965 · Cited by 15
BAJAJ, H. S., Aljabri, B. A., & Verma, S. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000562 · Cited by 14
Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies
Pistrosch, F., & Hanefeld, M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0678-2 · Cited by 14
Severe hypoglycemia exacerbates myocardial dysfunction and metabolic remodeling in diabetic mice
Huang, L., Zhou, Y., Chen, Z., Zhang, M., Zhan, Z., Wang, L., & Liu, L. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110692 · Cited by 13
COVID 19 and low-glucose levels: Is there a link?
Piarulli, F., & Lapolla, A. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108283 · Cited by 13
Lega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
Mellor, J., Kuznetsov, D., Heller, S. R., Gall, M.-A., Rosilio, M., Amiel, S. A., Ibberson, M. R., McGurnaghan, S. J., Blackbourn, L. A. K., Berthon, W., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06225-1 · Cited by 16
Rose, A. M. L., Bazioti, V., Hoogerland, J. A., Svendsen, A. F., Groenen, A. G., van Faassen, M. H. J. R., Rutten, M. G. S., Kloosterhuis, N., Dethmers-Ausema, B., Nijland, J. H., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101265 · Cited by 13
“Furthermore, acute insulin-induced hypoglycemia has been demonstrated to increase vWF levels in humans [83,84], likely the consequence of the hypoglycemia-induced increase in corticosterone levels [51,52] or endothelial dysfunction [84,85], and enhancing platelet aggregation.”
BackgroundNorris, T., Razieh, C., Yates, T. E., Zaccardi, F., Gillies, C., Chudasama, Y., Rowlands, A. V., Davies, M. J., McCann, G. P., Banerjee, A., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1709 · Cited by 13
He, A., Zuo, D., Liang, X., Guo, Y., Suxin, L., & Xia, Y. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104075 · Cited by 14
Safety of Rapid-Acting Insulin Analogs Versus Regular Human Insulin
Kitabchi, A. E., & Gosmanov, A. R. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182449ff9 · Cited by 11
“02).(14) Several landmark clinical trials have assessed the frequency and severity of hypoglycemia among individuals with diabetes and the impact on those patients.”
BackgroundLucci, C., Marongiu, A., Genovese, S., Mazza, M., Cosentino, N., & Marenzi, G. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02862-x · Cited by 12
Hypoglycemia-induced changes in complement pathways in type 2 diabetes
Moin, A. S. M., Nandakumar, M., Diboun, I., Al‐Qaissi, A., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2021) · Atherosclerosis Plus · doi:10.1016/j.athplu.2021.11.002 · Cited by 10
Eeg‐Olofsson, K., Nathanson, D., Spelman, T. D., Kyhlstedt, M., Seibold, A., Levrat‐Guillen, F., & Bolinder, J. (2025) · Diabetologia · doi:10.1007/s00125-025-06438-y · Cited by 12
“Acute or recurrent hypoglycaemia episodes are known to induce proinflammatory mediators, platelet activation and markers of vascular endothelial stress in type 1 diabetes [8, 9].”
Unger, J., & Parkin, C. G. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2306 · Cited by 9
Kościuszko, M., Buczyńska, A., Łuka, K., Duraj, E., Żuk-Czerniawska, K., Adamska, A., Siewko, K., Wiatr, A. A., Kretowski, A. J., & Popławska‐Kita, A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1329802 · Cited by 15
The Role of Bile Acid Sequestrants in the Management of Type 2 Diabetes Mellitus
Ganda, O. P. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0095 · Cited by 9
“Recent studies have documented the increased secretion of epinephrine and release of proinflammatory and prothrombotic cytokines in response to hypoglycemia.(18,19) This could potentially explain an underlying mechanism for the association of severe hypoglycemia with the increased mortality in ACCORD, although it rema…”
BackgroundMortality, Cardiovascular Morbidity and Possible Effects of Hypoglycaemia on Diabetic Complications
Chow, E., Fisher, M., & Heller, S. R. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch13 · Cited by 9
Diabetic Peripheral Neuropathy and Glycemia Risk Index in Type 2 Diabetes: A Cross-Sectional Study
Tang, Y., Zhang, P., Li, L., & Li, J. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s482824 · Cited by 12
Zhou, W., Zhang, L., & Liu, T. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s523442 · Cited by 9
Drummond, J., Soares, B. S., Vieira, É. L. M., Pedrosa, W., Teixeira, A. L., & Ribeiro‐Oliveira, A. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577446 · Cited by 10
Kishimoto, I. (2023) · Metabolites · doi:10.3390/metabo13060754 · Cited by 7
Cao, S., Tang, J., Fei, M., Jing, Q., Meng, F., Zhang, M., Liu, Q., Zhang, H., & Li, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1238774 · Cited by 7
Zijlstra, E., Heinemann, L., Fischer, A., & Kapitza, C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816668373 · Cited by 6
“A potential risk of this approach is that hypoglycemia in general is suggested to be related to a higher risk of micro and macrovascular complications.(18,19) When studying subjects under hypoglycemic conditions in a trial, the clamp method with relatively stable glucose concentrations around 60 mg/dL may however be c…”
BackgroundThe severity and duration of Hypoglycemia affect platelet-derived protein responses in Caucasians
Moin, A. S. M., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01639-w · Cited by 8
Hypoglycemia and Vascular Disease
Younk, L. M., & Davis, S. N. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.148247 · Cited by 6
Ishikawa-Tanaka, T., Hosojima, M., Kabasawa, H., Kaseda, R., Yasukawa, R., Yata, Y., Kuwahara, S., Kono, E., Takata, T., Iino, N., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00928-5 · Cited by 7
Widlansky, M. E., & Malik, M. A. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_8 · Cited by 8
Fatal Primary Capillary Leak Syndrome in a Late Preterm Newborn
Kulihova, K., Procházková, M., Šemberová, J., & Janota, J. (2016) · The Indian Journal of Pediatrics · doi:10.1007/s12098-016-2134-y · Cited by 6
“The other factor which can affect endothelial cells and lead to capillary leak might be severe postnatal hypoglycemia [5].”
BackgroundPerformance of a Blood Glucose Monitoring System in a Point-of-Care Setting
Ottiger, C., Gygli, N., Huber, A., Fernandez‐Tresguerres, B., Pardo, S. A., & Petruschke, T. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816638854 · Cited by 7
Jialal, I., & Dhindsa, S. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.06.006 · Cited by 6
Dangers of Hypoglycemia in Cardiac Patients With Diabetes
DEEDWANIA, P. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2138 · Cited by 7
Darouei, B., Amani‐Beni, R., Kakavand, N., Seifnezhad, A., Mazaheri‐Tehrani, S., Shekarian, A., Eshraghi, R., Bahrami, A., Amini‐Salehi, E., Hashemi, S. M., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02036-5 · Cited by 7
Hypoglycemia and Cardiovascular Disease: Exploring the Connections
Akhaury, K., Wanjari, A., Sinha, A. H., & Kumar, M. (2023) · Cureus · doi:10.7759/cureus.47784 · Cited by 6
“Functional issues that continue even after blood sugar levels have stabilized can lead to blood vessel thrombosis [24].”
BackgroundBrain Regulation of Cardiac Function during Hypoglycemia
Chambers, M. E., Nuibe, E. H., & Reno, C. M. (2023) · Metabolites · doi:10.3390/metabo13101089 · Cited by 7
Influence of cognitive impairment on the management of ischaemic stroke
Murao, K., Bombois, S., Cordonnier, C., Hénon, H., Bordet, R., Pasquier, F., & Leys, D. (2014) · Revue Neurologique · doi:10.1016/j.neurol.2014.01.665 · Cited by 6
The EURODIAB Prospective Complications Study
Gruden, G., Barutta, F., Chaturvedi, N., Schalkwijk, C. G., Stehouwer, C. D. A., Witte, D. R., Fuller, J., Perin, P. C., & Bruno, G. (2012) · Cited by 5
Drews, H., Castiglione, A. L., Brentin, S. N., Ersig, C., Dukatz, T., Harrison, B. E., Omran, F. M., & Rosenblatt, S. (2012) · PubMed · Cited by 6
The clinical impact of hypoglycemia in hospitalized patients
Borzì, V., & Fontanella, A. (2015) · Italian Journal of Medicine · doi:10.4081/itjm.2015.549 · Cited by 6
Wing, J., & Jivan, D. (2015) · South African Medical Journal · doi:10.7196/samj.2016.v106i1.10284 · Cited by 6
Ferhatbegović, L., Bećirović, M., Bečirović, E., Sarajlić, S., Ribić, A., Šarić, A., Bećirović, A., & Pojskić, B. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1765597 · Cited by 5
Verhulst, C. E. M., van Heck, J. I. P., Fabricius, T. W., Stienstra, R., Teerenstra, S., McCrimmon, R. J., Tack, C. J., Pedersen‐Bjergaard, U., & de Galan, B. E. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02095-w · Cited by 3
Cardiometabolic Risk Factors among Women with Eating Disorders in Saudi Arabia
Mohammedsaeed, W. M., & Shikieri, A. B. E. (2024) · Journal of Nutrition and Metabolism · doi:10.1155/2024/5953893 · Cited by 4
Low serum C-reactive protein levels predict 90-day mortality in hypoglycaemic patients
Bonaventura, A., Gallo, F., Carbone, F., Sacchi, G., Liberale, L., Dallegri, F., Maggi, D. C., Montecucco, F., & Cordera, R. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.05.008 · Cited by 4
Clayton, D., Woo, V. C., & Yale, J. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.09.088 · Cited by 6
RetractedWidlansky, M. E., & Malik, M. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_8-1 · Cited by 3
Origin of Typical Disease Sequelae
Straub, R. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803321-0.00005-7 · Cited by 3
Muratlı, S., Tufan, F., Soyluk, Ö., Bahat, G., & Karan, M. A. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s93925 · Cited by 3
Shi, J., Zhang, H., Wang, X., Weng, J., Ding, Y., Wu, J., Zheng, X., Luo, S., & Hu, H. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-079666 · Cited by 2
Forteath, C., Merchant, H. J., Kocherry, C., Murdoch, C. E., Kerr, J., Gallagher, J. R., Evans, M. L., Thorens, B., Pedersen‐Bjergaard, U., de Galan, B. E., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06574-5 · Cited by 2
The Cardiovascular Effects of Acute and Chronic Hypoglycemia
Dintakurti, A., Parikh, M. A., Silver, R., Frishman, W. H., & Peterson, S. J. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001114 · Cited by 2
Severe hypoglycemia and cardiovascular disease
Tak, S., & Jain, A. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100357 · Cited by 2
Insulin Treatment of Diabetes Mellitus-Tight vs. Conventional Control
Emanuele, N., & Reaven, P. D. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_34 · Cited by 2
Effect of Hypoglycemia and Rebound Hyperglycemia on Proteomic Cardiovascular Risk Biomarkers
Nandakumar, M., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2024) · Biomedicines · doi:10.3390/biomedicines12061137 · Cited by 3
Rehni, A. K., Cho, S., Liu, A., Lo, J., Kim, S. S., Khoury, N., Pérez‐Pinzón, M. A., Jy, W., & Dave, K. R. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16440 · Cited by 2
Lin, Y., Chen, C., Huang, L.-Y., Chen, B., Shao, Y. J., & Huang, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-10215-7 · Cited by 3
Chow, E., & Heller, S. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_34 · Cited by 2
Papachristoforou, E., Kountouri, A., Maratou, E., Kouretas, D., Skaperda, Z., Tsoumani, M. E., Efentakis, P., Ikonomidis, I., Lambadiari, V., & Makrilakis, K. (2022) · Healthcare · doi:10.3390/healthcare10081509 · Cited by 5
“In hypoglycemic clamp studies [12,13], with blood glucose levels maintained at 2.”
BackgroundAjie, M., van Heck, J. I. P., Verhulst, C. E. M., Fabricius, T. W., Hendriksz, M. S., McCrimmon, R. J., Pedersen‐Bjergaard, U., de Galan, B. E., Stienstra, R., & Tack, C. J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15712 · Cited by 1
Tian, J., Zhao, C., Li, Y., & Han, Y. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109151 · Cited by 1
Chang, S., Peng, Y., Luo, M., Lv, D., Li, N., Zhang, G., Jiang, Y., Ma, D., Huang, Y., Li, X., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07935-3 · Cited by 1
“In diabetic hypoglycemia research, studies have shown that hypoglycemia-induced pyroptosis substantially to endothelial dysfunction in diabetic animal models [13, 14].”
Hypoglycemia, insulin resistance, and cardiovascular disease: A possible link
Iqbal, A., Chaudhury, T., & Heller, S. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00028-1 · Cited by 1
Hypoglycemia, diabetes and atherosclerosis: is there a link?
Conget, I., & Giménez, M. (2011) · Diabetes Management · doi:10.2217/dmt.11.15 · Cited by 1
Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration
Moscardó, V., Bondía, J., Ampudia‐Blasco, F. J., Fanelli, C. G., Lucidi, P., & Rossetti, P. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0219 · Cited by 1
Hypoglycemia and the risk of stroke in patients with type 2 diabetes mellitus in older age groups
Ostroumova, O. D., Starodubova, A. V., Alexey, I. K., De, V. A., Оstroumova, Т. М., & Kiknadze, T. D. (2020) · Medical news of the North Caucasus · doi:10.14300/mnnc.2020.15144 · Cited by 1
A clinical cardiology perspective of thrombophilias
Becker, R. C. (2010) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-010-0511-3 · Cited by 1
“Last, acute insulin-induced hypoglycemia triggers activation and platelet monocyte aggregate formation [109].”
BackgroundType 1 Diabetes: Clinical and Experimental
Chiarelli, F., & Marcovecchio, M. L. (2010) · Yearbook of pediatric endocrinology · doi:10.1159/000320658 · Cited by 1
“Interestingly, the present study and a similar one published on the same issue of Diabetes Care [6], have shown, through physiological studies, that moderate acute hypoglycemia can activate several pathways known to damage the vasculature.”
ResultSandoval, D. A., Lamos, E. M., Younk, L. M., Hedrington, M. S., & Davis, S. N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.03833-2 · Cited by 1
Prevención de la enfermedad extracraneal carotídea en la atención primaria de salud
Rodríguez, T. C. (2014) · Revista Cubana de Angiología y Cirugía Vascular
Psychosocial factors and type 1 diabetes
Fickley, C. E. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Giménez, M. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Mechanisms of hypoglycaemia related sudden cardiac death in type 2 diabetes mellitus
Chow, E. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Grajower, M. M. (2015) · Endocrine Practice · doi:10.4158/ep14393.co
Hypoglycaemia and cardiovascular disease. The fatal linkage
Conget, I. (2011) · Avances en Diabetología · doi:10.1016/s1134-3230(11)70006-0
Imaging-based diagnosis of the carotid disease
Rodríguez, T. C. (2014) · Revista Cubana de Angiología y Cirugía Vascular
Prevention of the extracranial carotid disease at the primary health care
Rodríguez, T. C. (2014) · Revista Cubana de Angiología y Cirugía Vascular
Mechanism of Hypoglycemia-Associated Cardiovascular Diseases
Kang, Y. M., & Lee, W. J. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.1.24
“그 결과, 보상적 신 경내분비계 호르몬 증가와 동시에 tumor necrosis factoralpha, interleukin (IL)-1beta, IL-6, IL-8, 유리지방산, 백 혈구, 활성산소(reactive oxygan species) 등이 점적 정맥 주사로 서서히 저혈당을 유발한 Wright 등[9]과 Gogitidze 3차_JKDA 17권1호 05_(024-029) 이우제_ME.indd 27 2016-03-29 오전 11:50:31 Focused Issue 저혈당에 의한 심혈관질환 발생 기전 http://dx.doi.org/10.4093/jkd.2016…”
InfluentialParry, H. (2015) · Discovery Research Portal (University of Dundee)
Impacto cardiovascular de la hipoglicemia
Espitia, M. D. L. (2017) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.12.002 · Cited by 2
Miura, J., Kikuchi, S., Shimura, K., Babazono, T., & Uchigata, Y. (2018) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/5/4/001109
“DOI: 10.15226/2374- 6890/5/4/01109 Supplementary Table 1: Clinical factors correlated with RHI in all patients (n=25) Variable R P Age(years) -0.065 0.757 Duration(years) 0.137 0.513 BMI(kg/m2) -0.325 0.112 HbA1c(%) 0.262 0.206 GA(%) 0.471 0.02 LDL-C(mg/dl) 0.063 0.764 HDL-C(mg/dl) 0.337 0.099 eGFR(ml/min) -0.062 0.76…”
InfluentialNoh, R. M., Graveling, A. J., Lang, N. N., White, A. C., Lee, K. K., Mills, N. L., Newby, D. E., Lang, C. C., & Frier, B. M. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.258
Self-citationKim, W. J., Noh, J. H., Han, K., & Park, C. (2020) · Research Square · doi:10.21203/rs.3.rs-113357/v1
Tabassum, Y., Butt, M. Z. I., Roohi, N., Adnan, M., Khadka, S., Iqbal, M. A., Gupta, R. P., & Aryal, P. (2021) · Research Square · doi:10.21203/rs.3.rs-426616/v1
Raffali, M. A., Muhammad, S., Hamid, H. A., Nawi, A., & Kamaruddin, N. (2021) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.036.01.15
Lamos, E. M., Younk, L. M., & Davis, S. N. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch31
Chow, E., & Heller, S. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_35 · Cited by 1
(2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803321-0.09996-1
Clayton, D., Woo, V. C., & Yale, J. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.007 · Cited by 5
Ko, S. (2022) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2022.4.e13 · Cited by 1
Adjunct Drug Treatment to Reduce Vascular Disease in People with Diabetes
Jenkins, A. J. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_29
Santilli, F., & Simeone, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-96352-0_7
Wahab, N. A., Harryzan, N. H., Khoo, C. S., & Shah, S. A. (2025) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0045-1812065
Wakasugi, S., Mita, T., Katakami, N., Okada, Y., Yoshii, H., Osonoi, T., Kuribayashi, N., Taneda, Y., Kojima, Y., Gosho, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13544531
Moin, A. S. M., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2022) · Figshare · doi:10.6084/m9.figshare.21293688
Hsu, J.-C., Yang, Y.-Y., Chuang, S.-L., Yu, C., & Lin, L.-Y. (2021) · Figshare · doi:10.6084/m9.figshare.15047632
Metadata
- Authors
- Wright, R. J., Newby, D. E., Stirling, D., Ludlam, C. A., Macdonald, I. A., & Frier, B. M.
- Affiliations
- Edinburgh Royal Infirmary (GB)
- University of Edinburgh (GB)
- University of Nottingham (GB)
- Corresponding author
- Frier, Brian M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-07-01
- Volume
- 33
- Issue
- 7
- Pages
- 1591-1597
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890364
- OpenAlex
- W2144610870
- Cited by
- 208
- References
- 27
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 11 · 2023: 13 · 2022: 13 · 2021: 14 · 2020: 12 · 2019: 7 · 2018: 17 · 2017: 10 · 2016: 18 · 2015: 21 · 2014: 18 · 2013: 10 · 2012: 11
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Diabetes UK
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- insulin-induced hypoglycemia, inflammation, endothelial dysfunction, platelet activation, type 1 diabetes, CD40 expression, soluble CD40 ligand, C-reactive protein, P-selectin, von Willebrand factor, tissue plasminogen activator, thrombosis
- MeSH terms
- Adult, Blood Glucose, Blood Platelets, C-Reactive Protein, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Endothelium, Vascular, Female, Flow Cytometry, Humans, Hypoglycemia, Hypoglycemic Agents, Inflammation, Insulin, Male, Monocytes, Tissue Plasminogen Activator, Vasculitis, von Willebrand Factor, Biomarkers, Platelet Activation, Interleukin-6, P-Selectin, CD40 Antigens, CD40 Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.